409 filings
4
ALRN
Aileron Therapeutics Inc
1 May 24
Change in insider ownership
7:15pm
8-K
ALRN
Aileron Therapeutics Inc
1 May 24
Entry into a Material Definitive Agreement
5:25pm
424B5
ALRN
Aileron Therapeutics Inc
1 May 24
Prospectus supplement for primary offering
5:24pm
S-8
ALRN
Aileron Therapeutics Inc
1 May 24
Registration of securities for employees
5:16pm
FWP
ALRN
Aileron Therapeutics Inc
1 May 24
Free writing prospectus
8:54am
8-K
f9pk bfn2l5vukpdc9p5
1 May 24
Results of Operations and Financial Condition
8:40am
3
7jnurb
30 Apr 24
Initial statement of insider ownership
3:32pm
144
qpm9fuwlx19
29 Apr 24
Notice of proposed sale of securities
5:00pm
SC 13D/A
ut965xxq2gdvay dqcp9
16 Apr 24
Aileron Therapeutics / Satter Muneer A ownership change
5:16pm
8-K
1js5tqa20
15 Apr 24
Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
5:22pm
4/A
7fjvx8 y0hz
10 Apr 24
Aileron Therapeutics / RICKENBACH JOSEF H VON ownership change
4:15pm
4/A
u3rgkr2i58wjmc 9s
10 Apr 24
Aileron Therapeutics / Reinhard J. Ambros ownership change
4:15pm
3
gv9bq3rp2asxjqg4y
2 Apr 24
Aileron Therapeutics / Charles Garner ownership change
6:10pm
NT 10-K
m0omcwom808tdj
1 Apr 24
Notice of late annual filing
4:15pm
8-K
7bt8is776hfwp3 7lm
29 Mar 24
Departure of Directors or Certain Officers
8:03am
8-K
36v0t
15 Mar 24
Aileron Therapeutics Announces CEO Transition
7:00am
4
87hg4qaa78jt61s
6 Mar 24
AILERON THERAPEUTICS / JAMES BRIAN WINDSOR ownership change
5:06pm
SC 13G
ovz o721i
5 Mar 24
AILERON THERAPEUTICS / UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT ownership change
7:14pm